the result in 2Q18. This decrease was a result of the extraordinary items and also the new investments. Without these items, the Company reported an increase operating result of THB 78 million from the

from THB 20.9 Mn in 2016 to THB 20.1 Mn in 2017, a decrease of THB 0.8 Mn. This was mostly due to the losses from recently acquired Thai food business “Tummour” and premium Japanese food brand “Sushi Cyu

months, end of March 31, 2019 Financial Statement Consolidate financial statement % revenue from sales Q1/2019 Q1/2018 increase(decrease) Q1/2019 Q1/2018 Revenues from sales 67.47 56.46 11.01 19.50% 100.00

million. Sales revenue from beverage business decrease by 0.4% while sales revenue from food business decreased by 0.8%. The proportion of beverage business sales revenue to food business sales revenue was

expenses financial expenses and doubtful account Baht 0.57 million. Statement of Financial Position (Unit: million Baht) Financial Statement Q1/2019 Q1/2018 Increase (decrease) Consolidate financial

0.86 million. Statement of Financial Position (Unit: million Baht) Financial Statement Q2/2019 Q2/2018 Increase (decrease) Consolidate financial statement TOTAL ASSET 1,130.64 1,185.22 (54.58 ) (4.61

Financial Position (Unit: million Baht) Financial Statement Q2/2019 Q2/2018 Increase (decrease) Consolidate financial statement TOTAL ASSET 1,130.64 1,185.22 (54.58 ) (4.61%) TOTAL LIABILITIES 726.51 701.72

2020, the company had construction and service revenue of 466.47 THB mn, a decrease from the same period of year 2019 by 261.22 THB mn or equivalent to a decrese of 35.90 percent from the previous year

17.74% 20.03 9.21% 49.42 246.73% Jul – Sep 63 Jul – Sep 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2

1 Ref: CK-20-0000-AFD(AC)-L-0042 August 14, 2020 Subject: Clarification on Operating Result and Financial Position for the six-month period ended June 30, 2020 Attention: President The Stock Exchange